michael j. birrer, md, phd, regarding brca status in newly diagnosed ovarian cancer
Published 5 years ago • 25 plays • Length 1:01Download video MP4
Download video MP3
Similar videos
-
0:44
michael j. birrer, md, phd, on the role of maintenance therapy in newly diagnosed ovarian cancer
-
0:51
michael j. birrer, md, phd, considers the benefits of various parp inhibitors in ovarian cancer
-
2:41
michael birrer, md, on the key takeaways from the ovarian plenary session in ovarian cancer
-
28:33
michael j. birrer md, phd: future of ovarian cancer treatment: personalized medicine
-
0:51
michael j. birrer, md, phd, elaborates on the outcomes from the forward i study
-
2:30
dr. birrer on parp inhibitors in ovarian cancer
-
1:58
dr. birrer on the approval process in ovarian cancer
-
1:18
michael birrer on predicting outcomes in ovarian cancer
-
42:00
prospects for targeted therapy in ovarian cancer - by michael birrer, md, phd
-
1:15
dr. birrer on fda approval of rucaparib in ovarian cancer
-
3:16
dr. michael birrer on bevacizumab in ovarian cancers
-
2:34
dr. birrer on other targets in ovarian cancer
-
1:04
michael birrer discusses personalization of ovarian cancer care
-
1:49
dr. birrer on parp inhibitors in ovarian cancer
-
0:36
society of gynecologic oncology 50th anniversary: michael birrer, md, phd
-
1:56
dr. birrer on parp inhibitors in ovarian cancer
-
1:56
dr. birrer discusses the gog0218 and icon7 trials
-
1:34
dr. birrer discusses recurrent ovarian cancer treatment
-
8:00
the gcs project - research (part 1) with dr. michael birrer